Palisades Investment Partners’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q2
$2.04M Sell
19,500
-8,800
-31% -$889K 3.63% 2
2014
Q1
$2.78M Buy
28,300
+4,900
+21% +$454K 3.01% 4
2013
Q4
$2.2M Sell
23,400
-7,300
-24% -$673K 2.44% 11
2013
Q3
$2.66M Hold
30,700
2.5% 9
2013
Q2
$2.64M Buy
+30,700
New +$2.61M 2.62% 8

Other funds holding JNJ

Palisades Investment Partners's JNJ Position: Q2 2014 in Review

Palisades Investment Partners reduced its Johnson & Johnson (JNJ) stake by 31% in Q2 2014, selling an estimated $889K and leaving 19,500 shares worth $2.04M. The position accounts for 3.63% of the portfolio, ranked #2.

Palisades Investment Partners first reported a position in JNJ in Q2 2013 and has held it in 5 quarters since. The position peaked at $2.78M in Q1 2014. 1,976 funds tracked by Wall St. Rank hold JNJ as of Q2 2014.

  • Palisades Investment Partners held 19,500 shares of Johnson & Johnson worth $2.04M as of Q2 2014.
  • Palisades Investment Partners sold 8,800 Johnson & Johnson shares in Q2 2014, an estimated $889K.
  • Johnson & Johnson made up 3.63% of Palisades Investment Partners's portfolio in Q2 2014, its #2 holding.
  • Palisades Investment Partners first reported a position in Johnson & Johnson in Q2 2013 and has held it in 5 quarters since.
  • Palisades Investment Partners's Johnson & Johnson position peaked at $2.78M in Q1 2014.
  • 1,976 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2014.

Based on Palisades Investment Partners's 13F filing for Q2 2014, filed 28 Jul 2014.